| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/15/2006 | US20060127512 Modulating the inflammatory response in target cells by contacting the cells with a compund selected from dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone; cyclooxygenase inhibitors |
| 06/15/2006 | US20060127511 Modulation of inflammation by hops fractions and derivatives |
| 06/15/2006 | US20060127508 Preparation for the relief of disease |
| 06/15/2006 | US20060127506 Compositions of S-adenosyl-L-methionine |
| 06/15/2006 | US20060127505 Anti-inflammatory formulations |
| 06/15/2006 | US20060127503 Ulcerative colitis and Crohn's disease; 5-aminosalicylic acid or 4-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) |
| 06/15/2006 | US20060127502 Methods for inhibiting Stat3 signaling in immune cells |
| 06/15/2006 | US20060127501 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| 06/15/2006 | US20060127499 Vitamin-mineral compositions |
| 06/15/2006 | US20060127497 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 06/15/2006 | US20060127496 L-histidine in ophthalmic solutions |
| 06/15/2006 | US20060127492 Sustained improver of muscular fatigue |
| 06/15/2006 | US20060127491 By administering emulsion containing fish oil derived omega-3-fatty acid; free of phytosterols and plant derived fatty acids |
| 06/15/2006 | US20060127487 Antiviral compositions |
| 06/15/2006 | US20060127486 Ceramic structures for prevention of drug diversion |
| 06/15/2006 | US20060127485 Bio-degradable colloid particles, in particular for pulmonary applications |
| 06/15/2006 | US20060127484 Controlled release composition |
| 06/15/2006 | US20060127482 Combination of immuno gene therapy & chemotherapy for treatment of cancer & hyperproliferative diseases |
| 06/15/2006 | US20060127481 Ophthalmic drug delivery system using polymer micell |
| 06/15/2006 | US20060127477 Novel preparation and administration form comprising an acid-labile active compound |
| 06/15/2006 | US20060127476 Delayed release oral dosage for side effect reduction of nausea, headache; improve patient compliance in treating menorrhagia; prevents a bolus release of tranexamic acid in the stomach |
| 06/15/2006 | US20060127475 tablet comprising disintegrant such as carmellose, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose |
| 06/15/2006 | US20060127474 Pharmaceutical compositions comprising fluvastatin |
| 06/15/2006 | US20060127473 Compositions and methods for stabilizing active pharmaceutical ingredients |
| 06/15/2006 | US20060127472 Taste-masked prednisolone oral formulations |
| 06/15/2006 | US20060127471 Storage stable liposome; administering by injection; coupling with phosphatides and polyoxyethylene glycol |
| 06/15/2006 | US20060127470 Use of buckysome or carbon nanotube for drug delivery |
| 06/15/2006 | US20060127469 Entrapping in phosphatidylcholine component; room temperature transdermal delivery system; long shelf life |
| 06/15/2006 | US20060127468 Methods and related compositions for reduction of fat and skin tightening |
| 06/15/2006 | US20060127464 Female hormone-containing patch |
| 06/15/2006 | US20060127459 Urogenital infection inhibition |
| 06/15/2006 | US20060127452 Method and composition for reducing cravings for a craved substance |
| 06/15/2006 | US20060127451 Coating composition |
| 06/15/2006 | US20060127450 Composition containing higher fatty acid derivative and foods and drinks |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127441 Device for stimulating the female sexual organ, packaging and dispensing member |
| 06/15/2006 | US20060127440 Drug delivery systems for the prevention and treatment of vascular diseases |
| 06/15/2006 | US20060127438 Overcoating a medical insert with active materials to prevent infections; coating releases a chemotherapeutic agent such as 5-fluorouracil which reduces, inhibits, or prevents the growth or transmission of foreign organisms |
| 06/15/2006 | US20060127431 Agmatine combined with BHT, BHA, hexamidine, cetyl pyridinium chloride, green tea catechins, phytosterols, ursolic acid and/or plant extracts in carrier; reducing shaving frequency |
| 06/15/2006 | US20060127430 the Zeolite cage complexes do not absorb into skin and affect a controlled release upon contact with water; skin aging, anti-wrinkle, antioxidants, skin whitening, acne, rosace, sun screens, UV blocks, anesthetics, skin soothers, anti-irritants, anti-inflammatory agents, vitamins, hormones |
| 06/15/2006 | US20060127429 Topical numbing composition for laser therapy |
| 06/15/2006 | US20060127423 Organic compounds |
| 06/15/2006 | US20060127421 Treatment using D-threo methylphenidate |
| 06/15/2006 | US20060127420 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 06/15/2006 | US20060127405 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 06/15/2006 | US20060127404 Hinge core mimetibodies, compositions, methods and uses |
| 06/15/2006 | US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/15/2006 | US20060127387 Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions |
| 06/15/2006 | US20060127385 Method for sustaining enos activity |
| 06/15/2006 | US20060127384 Coenzyme Q10 as antiapoptotic agent |
| 06/15/2006 | US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2006 | US20060127375 Cryopreservation of human red blood cells |
| 06/15/2006 | US20060127361 Compositions and methods for inducing gene expression |
| 06/15/2006 | US20060127357 Rapamycin and il-10 for the treatment of immune diseases |
| 06/15/2006 | US20060127354 Phosphorylated polymers and conjugates thereof |
| 06/15/2006 | US20060127353 Fat-binding polymers |
| 06/15/2006 | US20060127352 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 06/15/2006 | US20060127351 Process for preparing high molar mass polymers |
| 06/15/2006 | US20060127349 Administering water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors |
| 06/15/2006 | US20060127348 Chemically and/or biologically reactive compounds |
| 06/15/2006 | US20060127342 Taurine-based compositions, therapeutic methods, and assays |
| 06/15/2006 | US20060127326 Oral hygiene product for human and animal use with a melatonin base as an active product |
| 06/15/2006 | US20060127323 Formoterol and ciclesonide combination |
| 06/15/2006 | US20060127322 Stable pharmaceutical Budesonide preparation for producing propellant-free aerosols |
| 06/15/2006 | US20060127321 Pharmaceutical foam |
| 06/15/2006 | US20060127320 Method of delivering parathyroid hormone to a human |
| 06/15/2006 | US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems |
| 06/15/2006 | US20060127318 Composition and method of a topical treatment of neurodermatitis |
| 06/15/2006 | US20060127315 Methods of treating humans undergoing injection of a contrast agent |
| 06/15/2006 | US20060127310 Amplification of biotin-mediated targeting |
| 06/15/2006 | US20060127307 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 06/15/2006 | US20060127306 Radioactively labelled amino acid analogues, their preparation and use |
| 06/15/2006 | CA2849147A1 Compositions comprising a taxoid and a benzimidazole carbamate for the treatment of cancer |
| 06/15/2006 | CA2638753A1 Methods, assays and compositions for treating retinol-related diseases |
| 06/15/2006 | CA2630088A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | CA2600898A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | CA2594103A1 Medicament for hygienic application inside the ear |
| 06/15/2006 | CA2594102A1 Pyrazine dicarboxamides and the use thereof |
| 06/15/2006 | CA2593034A1 Compositions and methods based upon the kinase haspin |
| 06/15/2006 | CA2591332A1 Methylene inhibitors of matrix metalloproteinase |
| 06/15/2006 | CA2591296A1 Stabilisation of glucocorticoid esters with acids |
| 06/15/2006 | CA2591247A1 Treatment of patients suffering from a disease having a family history or diagnosis of tics or tourette's syndrome with d-threo methylphenidate |
| 06/15/2006 | CA2591203A1 Topical drug delivery system |
| 06/15/2006 | CA2590962A1 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 06/15/2006 | CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/15/2006 | CA2590748A1 Aryl amide sphingosine 1-phosphate analogs |
| 06/15/2006 | CA2590737A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 06/15/2006 | CA2590711A1 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/15/2006 | CA2590585A1 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/15/2006 | CA2590277A1 Product containing prostaglandin having fluorine atom in its molecule |
| 06/15/2006 | CA2590252A1 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides |
| 06/15/2006 | CA2590247A1 .omega.-phenyloctanamides |
| 06/15/2006 | CA2590160A1 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 06/15/2006 | CA2590136A1 Compositions and methods for treating conditions of the nail unit |
| 06/15/2006 | CA2590115A1 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 06/15/2006 | CA2590013A1 Pharmaceutical formulations cytidine analogs and derivatives |
| 06/15/2006 | CA2589981A1 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy |
| 06/15/2006 | CA2589966A1 Novel diazabicyclononene derivative |
| 06/15/2006 | CA2589935A1 Nucleosides with antiviral and anticancer activity |
| 06/15/2006 | CA2589928A1 Process for the preparation of drospirenone |